We've found
					52,953 Cancer				
					clinical trials				
				
			
		
							
  	
	Non-Small Cell Lung Cancer Clinical Trial
	Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage IIB or IIIA Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Lung Cancer Clinical Trial
	Collection of Sputum and Labeling for Lung Cancer
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Urinary Bladder Neoplasms Clinical Trial
	A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Urinary Bladder Neoplasms Clinical Trial
	A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Urinary Bladder Neoplasms Clinical Trial
	A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Urinary Bladder Neoplasms Clinical Trial
	A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Urinary Bladder Neoplasms Clinical Trial
	A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Rectal Cancer Clinical Trial
	Study of Durvalumab (MEDI4736) After Chemo-Radiation for Microsatellite Stable Stage II-IV Rectal Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neoplasms Clinical Trial
	This Study Aims to Find the Best Dose of BI 907828 in Patients With Different Types of Advanced Cancer (Solid Tumors)
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF)
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	A Study of Olaparib and Low Dose Radiotherapy for Small Cell Lung Cancer
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Sym023 (Anti-TIM-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Triple Negative Breast Cancer Clinical Trial
	A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Triple Negative Breast Cancer Clinical Trial
	A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Triple Negative Breast Cancer Clinical Trial
	A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Cancer Clinical Trial
	Nab-paclitaxel in Combination With Gemcitabine for Pediatric Relapsed and Refractory Solid Tumors
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Small Cell Lung Cancer Clinical Trial
	Study of Irinotecan Liposome Injection (ONIVYDE®) in Patients With Small Cell Lung Cancer
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology, Reproductive Clinical Trial
	HuMax-AXL-ADC Safety Study in Patients With Solid Tumors
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology, Other Clinical Trial
	Use of Human Dehydrated Amnion Chorion Allograft in Laryngectomy/Pharyngectomy
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 4/2/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Prostate Cancer Clinical Trial
	Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	A Study of Nivolumab in Selected Uterine Cancer Patients
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Solid Tumors Clinical Trial
	A Study of RO7172508 in Patients With Locally Advanced and/or Metastatic CEA-Positive Solid Tumors
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Breast Cancer Clinical Trial
	A Study of Rucaparib Administered With Radiation in Patients With Triple Negative Breast Cancer With an Incomplete Response Following Chemotherapy
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Pancreatic Cancer Clinical Trial
	Use of High-dose Radiation Therapy Plus Chemotherapy to Improve the Likelihood of Surgical Treatment in Patients With Locally Advanced Pancreatic Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Breast Cancer Clinical Trial
	Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Neoplasms Clinical Trial
	A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-64619178, an Inhibitor of Protein Arginine Methyltransferase 5 (PRMT5) in Participants With Advanced Cancers
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Pancreatic Cancer Clinical Trial
	Long Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Prostate Cancer Clinical Trial
	A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Prostate Cancer Clinical Trial
	A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Axitinib and Nivolumab in Treating Participants With Unresectable or Metastatic TFE/Translocation Renal Cell Carcinoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Axitinib and Nivolumab in Treating Participants With Unresectable or Metastatic TFE/Translocation Renal Cell Carcinoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Axitinib and Nivolumab in Treating Participants With Unresectable or Metastatic TFE/Translocation Renal Cell Carcinoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Axitinib and Nivolumab in Treating Participants With Unresectable or Metastatic TFE/Translocation Renal Cell Carcinoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Axitinib and Nivolumab in Treating Participants With Unresectable or Metastatic TFE/Translocation Renal Cell Carcinoma
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	A Study of TPX-0005 in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	REACTION (Radiation Enhanced Assessment of Combination Therapies in Immuno-ONcology) - Nivolumab or Nivolumab in Combination With Other Immuno-oncology (IO) Agents After Targeted Systemic Radiation in Patients With Advanced Esophagogastric Cancer
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Breast Cancer Female Clinical Trial
	GammaPod Registry and Quality of Life Nomogram
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Triple Negative Breast Cancer Clinical Trial
	Study of Adagloxad Simolenin (OBI-822) and OBI-821 Versus Placebo Treatment for High Risk Early Stage Triple Negative Breast Cancer Patients (TNBC) Following Neoadjuvant or Adjuvant Chemotherapy.
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Cervical Cancer Clinical Trial
	A Trial of Tisotumab Vedotin in Cervical Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Renal Cell Carcinoma Clinical Trial
	High Dose IL 2 and Entinostat in RCC
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Dabrafenib and/or Trametinib Rollover Study
		Status: Enrolling,
							Phase
													 IV			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Small Cell Lung Cancer Clinical Trial
	A Phase 1 Study Evaluating the Safety, Tolerability and Efficacy of AMG 119 in Subjects With RR SCLC
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Breast Cancer Clinical Trial
	A Study of ZN-c5 in Subjects With Breast Cancer
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Metastatic Colorectal Cancer Clinical Trial
	Dabrafenib + Trametinib + PDR001 In Colorectal Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Polycythemia Vera Clinical Trial
	KRT-232 Compared to Ruxolitinib in Patients With Phlebotomy-Dependent Polycythemia Vera
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Non-Small Cell Lung Cancer Clinical Trial
	A Trial of Pembrolizumab in Combination With Chemotherapy and Radiotherapy in Stage III NSCLC (KEYNOTE-799, MK-3475-799).
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
	Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Renal Cell Carcinoma Clinical Trial
	A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Breast Cancer Clinical Trial
	DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology Clinical Trial
	Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Solid Tumors Clinical Trial
	Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Oncology, Psychiatry / Psychology Clinical Trial
	The Promoting Resilience in Stress Management (PRISM) Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Cancer Clinical Trial
	The Effect of EMT on Anxiety Levels and Perception of Waiting Time in the Radiation Oncology Waiting Room
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Advanced Non-Small Cell Lung Cancer Clinical Trial
	RO5126766 for Patients With Advanced KRAS-Mutant Lung Cancer
		Status: Enrolling,
							Phase
													 I			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Ovarian Cancer Clinical Trial
	Circulating Tumour DNA as a Marker of Residual Disease & Response to Adjuvant Chemotherapy in Stage I-IV Ovarian Cancer
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Ovarian Cancer Clinical Trial
	Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
							
  	
	Ovarian Cancer Clinical Trial
	Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	
  
						
				
			
We've found
					52,953 Cancer
				
					clinical trials
				
				
				
	Non-Small Cell Lung Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage IIB or IIIA Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Lung Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  Collection of Sputum and Labeling for Lung Cancer
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Urinary Bladder Neoplasms Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Urinary Bladder Neoplasms Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Urinary Bladder Neoplasms Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Urinary Bladder Neoplasms Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Urinary Bladder Neoplasms Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Rectal Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  Study of Durvalumab (MEDI4736) After Chemo-Radiation for Microsatellite Stable Stage II-IV Rectal Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neoplasms Clinical Trial
	
Updated: 12/31/1969
  
  
  This Study Aims to Find the Best Dose of BI 907828 in Patients With Different Types of Advanced Cancer (Solid Tumors)
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF)
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Olaparib and Low Dose Radiotherapy for Small Cell Lung Cancer
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Sym023 (Anti-TIM-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Triple Negative Breast Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Triple Negative Breast Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Triple Negative Breast Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  Nab-paclitaxel in Combination With Gemcitabine for Pediatric Relapsed and Refractory Solid Tumors
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Small Cell Lung Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  Study of Irinotecan Liposome Injection (ONIVYDE®) in Patients With Small Cell Lung Cancer
		Status: Enrolling,
							Phase
																				 II,  III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer (EV-301)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology, Reproductive Clinical Trial
	
Updated: 12/31/1969
  
  
  HuMax-AXL-ADC Safety Study in Patients With Solid Tumors
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology, Other Clinical Trial
	
Updated: 4/2/2018
  
  
  Use of Human Dehydrated Amnion Chorion Allograft in Laryngectomy/Pharyngectomy
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 4/2/2018
Click here to add this to my saved trials
	    
		
	Prostate Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Nivolumab in Selected Uterine Cancer Patients
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Solid Tumors Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of RO7172508 in Patients With Locally Advanced and/or Metastatic CEA-Positive Solid Tumors
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Breast Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Rucaparib Administered With Radiation in Patients With Triple Negative Breast Cancer With an Incomplete Response Following Chemotherapy
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Pancreatic Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  Use of High-dose Radiation Therapy Plus Chemotherapy to Improve the Likelihood of Surgical Treatment in Patients With Locally Advanced Pancreatic Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Breast Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Neoplasms Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-64619178, an Inhibitor of Protein Arginine Methyltransferase 5 (PRMT5) in Participants With Advanced Cancers
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Pancreatic Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  Long Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Prostate Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Prostate Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Axitinib and Nivolumab in Treating Participants With Unresectable or Metastatic TFE/Translocation Renal Cell Carcinoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Axitinib and Nivolumab in Treating Participants With Unresectable or Metastatic TFE/Translocation Renal Cell Carcinoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Axitinib and Nivolumab in Treating Participants With Unresectable or Metastatic TFE/Translocation Renal Cell Carcinoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Axitinib and Nivolumab in Treating Participants With Unresectable or Metastatic TFE/Translocation Renal Cell Carcinoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Axitinib and Nivolumab in Treating Participants With Unresectable or Metastatic TFE/Translocation Renal Cell Carcinoma
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of TPX-0005 in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  REACTION (Radiation Enhanced Assessment of Combination Therapies in Immuno-ONcology) - Nivolumab or Nivolumab in Combination With Other Immuno-oncology (IO) Agents After Targeted Systemic Radiation in Patients With Advanced Esophagogastric Cancer
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Breast Cancer Female Clinical Trial
	
Updated: 12/31/1969
  
  
  GammaPod Registry and Quality of Life Nomogram
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Triple Negative Breast Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  Study of Adagloxad Simolenin (OBI-822) and OBI-821 Versus Placebo Treatment for High Risk Early Stage Triple Negative Breast Cancer Patients (TNBC) Following Neoadjuvant or Adjuvant Chemotherapy.
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Cervical Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Trial of Tisotumab Vedotin in Cervical Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Renal Cell Carcinoma Clinical Trial
	
Updated: 12/31/1969
  
  
  High Dose IL 2 and Entinostat in RCC
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Dabrafenib and/or Trametinib Rollover Study
		Status: Enrolling,
							Phase
													 IV			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Small Cell Lung Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Phase 1 Study Evaluating the Safety, Tolerability and Efficacy of AMG 119 in Subjects With RR SCLC
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Breast Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of ZN-c5 in Subjects With Breast Cancer
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors
		Status: Enrolling,
							Phase
																				 I,  II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Metastatic Colorectal Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  Dabrafenib + Trametinib + PDR001 In Colorectal Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Polycythemia Vera Clinical Trial
	
Updated: 12/31/1969
  
  
  KRT-232 Compared to Ruxolitinib in Patients With Phlebotomy-Dependent Polycythemia Vera
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Non-Small Cell Lung Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  A Trial of Pembrolizumab in Combination With Chemotherapy and Radiotherapy in Stage III NSCLC (KEYNOTE-799, MK-3475-799).
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
	
Updated: 12/31/1969
  
  
  Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Renal Cell Carcinoma Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Breast Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  DS-8201a Versus T-DM1 for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane [DESTINY-Breast03]
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Solid Tumors Clinical Trial
	
Updated: 12/31/1969
  
  
  Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Oncology, Psychiatry / Psychology Clinical Trial
	
Updated: 12/31/1969
  
  
  The Promoting Resilience in Stress Management (PRISM) Intervention: a Multi-site Randomized Controlled Trial for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  The Effect of EMT on Anxiety Levels and Perception of Waiting Time in the Radiation Oncology Waiting Room
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Advanced Non-Small Cell Lung Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  RO5126766 for Patients With Advanced KRAS-Mutant Lung Cancer
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Ovarian Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  Circulating Tumour DNA as a Marker of Residual Disease & Response to Adjuvant Chemotherapy in Stage I-IV Ovarian Cancer
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Ovarian Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
		
	Ovarian Cancer Clinical Trial
	
Updated: 12/31/1969
  
  
  Avelumab and Talazoparib in Untreated Advanced Ovarian Cancer (JAVELIN OVARIAN PARP 100)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials